EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS091-30749 
Organism
Homo sapiens 
Tissue/cell
HepG2 
Coordinate
chr20:34320060-34322100 
Target genes
TF binding sites/motifs
Number: 4             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
Foxq1MA0040.1chr20:34321986-34321997AATTGTTTATT+6.02
IRF1MA0050.2chr20:34321529-34321550AAAAAAAAAGAAAAAGAAAAA-6.09
Nr2f6(var.2)MA0728.1chr20:34320261-34320276AAGGTCAGGAGTTCA+6.04
Nr2f6(var.2)MA0728.1chr20:34321313-34321328GAGGTCAGGAGTTCA+6.22
Number of super-enhancer constituents: 3             
IDCoordinateTissue/cell
SE_17562chr20:34321563-34324732CD4p_CD25-_CD45RAp_Naive
SE_18082chr20:34321713-34324444CD4p_CD25-_CD45ROp_Memory
SE_22404chr20:34321703-34324666CD8_primiary
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr203432073634320776
chr203432130134321421
Number: 1             
IDChromosomeStartEnd
GH20I035733chr203432156434324732
Enhancer Sequence
AGAAGAAAAA AACTCGCCAT TATCATGCTG GCTTAAGAAC CCACCAAAAT ATACTACCTT 60
TTATGGCCAG AATCATTTTT TCATCCTTTC ATAAATTTCT TTGGCTAGTT TTACTATGAT 120
ACAATGGTAC ATAATCATAC TTAAAAAAAA AAAAAAATCC TGTAATCTCA GCACTTTGGT 180
AGGCCGAGGC AGGCAGATCA CAAGGTCAGG AGTTCAAGAC CAGTCTGGCC AATGTAGTGA 240
AACCCCGTCC CTAATAAAAA TACAAAAATT AGCCGGGCAT AGTACCGTGC GCCTGTAGTC 300
CCAGCTACTC GGGAGGCTAA GGCAGGAGAA TTGCTCAAAC CCGGGAAGCG GAGGTTGCAG 360
TGAGCCAAGA TCCCGCCACT GGTACTCCAG CCTGGGCGAC AGAGTAAGAC TCTGTCTAAA 420
AAAATTGCTA CGTATAGTAA ACAATATCCC TTTTGCCTTA TATTAACATT ACTGAAAATC 480
AGCAGACAAG ACATTATTTG AAAGACACCA TCCTCTAAGA GTAGAACTGC AATTATCTCC 540
TGAGAGTTAG CTATAGCTTT AACAAGCAAA AGGGCTTGTT GGCAAATACA AATCAAAATG 600
TGAACCTTTA AATAGTTTGT CATACAACAG GCCAACAAAA GCATTACTGT AATCCACAAA 660
ATAAATTAAT AAAACAAACT TACAATAGAA TATTTTCACA TTCAAGTACT AGTACTGGTT 720
CATTTATAAA AATTTTCATC AAATATAGTA ATTTACCATT AAGTCAATTT TGCCCCCATT 780
TACATATGGA AATATTTAAC ACGTTCAAAG GGTCACATAG ACATCAACAT TTTGGTTTTC 840
ATGGGCAAAA CCGTAATGAC AAAGGACAAT AAGAACTAAT GCAGGCCAGT GCAGTGGCTC 900
ACGCCTGTAA TCCCAACCCT TTGGGAGGCC GAGGCAGGCA GATCACTTGA GGTCAGGAGT 960
TTGAGACCAG CCCGGCCAAC ACGGTGAAAT CCCCTCTCTA CCAAAAATAC AAAAATTAGC 1020
CAGGCCTGAT GGTGCATGCC GGTAATCACA GCTACTTGGG AGGCTGAAGC AAGAGAATTG 1080
CTTGAACCCG GGAGGTGGAG GTTGCAGCAA GCTGAGACCA TGCCATTGCA CTCCAGCCTG 1140
GGCAAAAAGA GCAAAACACC ATCTCAAAAA AAAAAAAAAA AACCCAACTC CAAGTGCGGT 1200
GGCTCACACC TGTAATCTCA GCACTTTGGG AGGCTGAGGA AGGCAGGTCA CCTGAGGTCA 1260
GGAGTTCAAG ACCAGCCTAG TCGACACGGT GAAAACCCAT CTCTACTAAA AAATGCAAGA 1320
AGTAGTGGGT CGTGGTGGCA CAGGCCTGTA GTTCCAGCTA CTGTGGAGGC TGAGGCAGGA 1380
GAATCGCTTG AACCTGGGAG GCAGAGGTTG GAGTGAGCCG AAATCATGCC ACTGTACTCC 1440
AGCCTGAGCA ACAGAGCAAG ACTGTCTCCA AAAAAAAAGA AAAAGAAAAA GAACTAACGC 1500
ATTAAAATAC AATTTGACAT TCCTAGACTT TAATGTGACC ATTTCAAATA CTTCCTAAAG 1560
TTACAATGAA TACACCAGAA AATGGAGTAT GCCATTTTTA AGCCAGTTTA TAGAAACCTG 1620
TGGGATGCAA TCAAAACCAA TGATCAACTT GACCTTCACA GACCTTTTTA AAATCTCTAA 1680
CTAAAAACCA AAAAAGCCAA ACATATCTTT CTGCTCACTT CCGTAGTCTT CACAGTATAC 1740
CACCCATTCA TAATTAAATC TTATAATCTA TACCTCTGTG TCATCACCCA AATTTTAGAG 1800
GTGCCTTCAG ATATTTCAAT ATAAATTGAA AGACATTTCA AAATCAGTTT ATTCCACGAA 1860
AATGTCTATT TGTAGTGGCT TAATGATTAA ACATTTTGAC AATTCTGTAT CATTATCTGG 1920
ATATGTAATT GTTTATTCCT TATCAAAGCA AAGTTACATA TCACAAGAGC AACTGAGGTC 1980
TGCCTCAGAG AACCTGTAAG CAGGTCATCT TTAGAGTGCA TTGAAAATAG AAAATGAAGA 2040